{"status":"success","data":{"title":"Pneumonia Risk Stratification Tools","slug":"pneumonia-severity","tags":null,"collection":["pulmonology","infectious disease","ebm"],"content":"\n# Pneumonia: Risk Stratification Scoring Tools\n\n## Pneumonia Severity Index (PSI) \n\n-   From Pneumonia Patient Outcomes Research Team (PORT) \n-   A large derivation and validation study with &gt; 50,000 patients\n-   Best identifies low-risk/ low-mortality patients\n-   Tends to miss higher-risk pneumonia in younger patients because score is based on age \n-   Does not factor in immunosuppression (eg. HIV) and poor social support. \n\n| **Risk factors**                    | **Points**     |\n|-------------------------------------|----------------|\n| Men                                 | Age (years)    |\n| Women                               | Age (years)-10 |\n| Nursing home resident               | +10            |\n| History of neoplasm                 | +30            |\n| History of liver disease            | +20            |\n| History of heart failure            | +10            |\n| History of stroke                   | +10            |\n| History of renal failure            | +10            |\n| Altered mental status               | +20            |\n| RR ≥ 30 breaths/ min                | +20            |\n| SBP &lt; 90 mmHg                    | +20            |\n| Temp &lt; 95F (35C) or ≥104F (40C)  | +15            |\n| HR ≥ 125 bpm                        | +10            |\n| Arterial pH &lt; 7.35               | +30            |\n| BUN &gt; 30 mg/dL                   | +20            |\n| Na &lt; 130 mmol/L                  | +20            |\n| Glucose ≥250 mg/dL                  | +10            |\n| Hematocrit &lt; 30%                 | +10            |\n| PaO2 &lt; 60 mmHg                   | +10            |\n| Pleural effusion                    | +10            |\n\n| **PSI Class**  | **Total points** | **30-day mortality**  | **Disposition** |\n|---------|------------------|-------------|-----------------|\n| I       | &lt; 51          | 0.1%        | Outpatient      |\n| II      | 51-70            | 0.6%        | Outpatient      |\n| III     | 71-90            | 0.9%        | Outpatient vs short-stay inpatient        |\n| IV      | 91-130           | 9.3%        | Inpatient       |\n| V       | &gt; 130         | 27.0%       | Inpatient ICU   |\n\n([Fine et al., JAMA 1997)](http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086)\n\n## CURB-65 Severity Score\n\n\\* Supported by British Thoracic Society (BTS)\n\n-   Best identifies high-risk/ high-mortality patients\n-   Tends to misclassify moderate-risk pneumonia patients (as low-risk) \n-   Does not account for co-morbidities and hypoxemia\n\n|        | **Risk factor**                                   | **Points** |\n|--------|---------------------------------------------------|------------|\n| **C**  | **C**onfusion                                     | 1          |\n| **U**  | Uremia (BUN &gt;19 mg/dL)                         | 1          |\n| **R**  | **R**R ≥ 30 breaths/min                           | 1          |\n| **B**  | **B**P low (SBP &lt; 90 mmHg or DBP &lt; 60 mmHg) | 1          |\n| **65** | Age ≥ **65** years                                | 1          |\n\n| **Total points** | **30-day mortality**  | **Disposition**                    |\n|------------------|-------------|------------------------------------|\n| 0                | 0.6%        | Outpatient                         |\n| 1                | 3.2%        | Outpatient                         |\n| 2                | 13.0%       | Outpatient or short-stay inpatient |\n| 3                | 17%         | Inpatient                          |\n| 4                | 41.5%       | Inpatient, likely ICU              |\n| 5                | 57.0%       | Inpatient ICU                      |\n\n([British Thoracic Society Standards of Care Committee](http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364) &[ ](http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136)[Aujesky et al, Am J Med, 2005](http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136)) \n\n## SMART-COP\n\nSupported by Australian CAP Study\n\n-   Tool to predict need for intensive respiratory or vasopressor support (IRVS) \n\n<table>\n<colgroup>\n<col width=\"33%\" />\n<col width=\"33%\" />\n<col width=\"33%\" />\n</colgroup>\n<thead>\n<tr class=\"header\">\n<th><br />\n</th>\n<th><strong>Risk factor</strong></th>\n<th><strong>Points</strong></th>\n</tr>\n</thead>\n<tbody>\n<tr class=\"odd\">\n<td><strong>S</strong></td>\n<td><strong>S</strong>ystolic BP &lt; 90 mmHg</td>\n<td>2</td>\n</tr>\n<tr class=\"even\">\n<td><strong>M</strong></td>\n<td><strong>M</strong>ultilobar CXR involvement</td>\n<td>1</td>\n</tr>\n<tr class=\"odd\">\n<td><strong>A</strong></td>\n<td><strong>A</strong>lbumin &lt; 3.5 g/dL</td>\n<td>1</td>\n</tr>\n<tr class=\"even\">\n<td><strong>R</strong></td>\n<td>If age ≤ 50 years: <strong>R</strong>R ≥ 25 breaths/min <br />\nIf age &gt; 50 years: <strong>R</strong>R ≥ 30 breaths min <br />\n</td>\n<td>1</td>\n</tr>\n<tr class=\"odd\">\n<td><strong>T</strong></td>\n<td><strong>T</strong>achycardia HR ≥ 125 bpm </td>\n<td>1</td>\n</tr>\n<tr class=\"even\">\n<td><strong>C</strong></td>\n<td><strong>C</strong>onfusion (new onset)</td>\n<td>1<br />\n</td>\n</tr>\n<tr class=\"odd\">\n<td><strong>O</strong></td>\n<td><strong>O</strong>xygen low<br />\n\n<p>If age ≤50 years: </p>\n<ul>\n<li>PaO2 &lt; 70 mmHg, or<br />\n</li>\n<li>O2 sat ≤ 93%, or<br />\n</li>\n<li>PaO2/FiO2 &lt; 333<br />\n</li>\n</ul>\n<p>If age &gt;50 years:</p>\n<ul>\n<li>PaO2 &lt; 60 mmHg, or</li>\n<li>O2 sat ≤ 90%, or </li>\n<li>PaO2/FiO2 &lt; 250 </li>\n</ul></td>\n<td>2</td>\n</tr>\n<tr class=\"even\">\n<td><strong>P</strong></td>\n<td>Arterial <strong>p</strong>H &lt; 7.35</td>\n<td>2</td>\n</tr>\n</tbody>\n</table>\n\n| **Total points** | **Risk of needing IRVS** |\n|------------------|--------------------------|\n| 0-2              | Low                      |\n| 3-4              | Moderate ( 1 in 8)       |\n| 5-6              | High (1 in 3)            |\n| ≥ &              | Very high (2 in 3)       |\n\n([Charles et al., Clin Infect Dis, 2008](http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884))\n\n## References\n\n-   [Aujesky D et. al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005 Apr;118(4):384-92.](http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136)\n-   [Fine MJ et. al. A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med. 1997 Jan 23;336(4):243-50.](http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086)\n-   [Charles PG et. al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis. 2008 Aug 1;47(3):375-84.](http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884)\n-   [British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax. 2001 Dec;56 Suppl 4:IV1-64.](http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364)\n"}}